Genmab A/S (CPH:GMAB)
1,291.50
-1.50 (-0.12%)
Apr 16, 2025, 4:59 PM CET
Genmab Employees
Genmab had 2,682 employees as of December 31, 2024. The number of employees increased by 478 or 21.69% compared to the previous year.
Employees
2,682
Change (1Y)
478
Growth (1Y)
21.69%
Revenue / Employee
8.03M DKK
Profits / Employee
2.92M DKK
Market Cap
81.91B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
Novo Nordisk | 77,349 |
Coloplast | 16,639 |
Demant | 22,639 |
ALK-Abelló | 2,753 |
Zealand Pharma | 335 |
Ambu A/S | 5,196 |
H. Lundbeck | 5,707 |
GN Store Nord | 7,347 |
Genmab News
- 3 days ago - Genmab's Outlook Beyond Darzalex's Patent Cliff - Seeking Alpha
- 3 days ago - Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2025 - GlobeNewsWire
- 4 days ago - Transactions in Connection with Share Buy-back Program - GlobeNewsWire
- 8 days ago - Genmab A/S Share Capital Reduction - GlobeNewsWire
- 11 days ago - Transactions In Connection with Share Buy-back Program - GlobeNewsWire
- 17 days ago - Transactions With Shares and Linked Securities in Genmab A/S Made by Managerial Employees and Their Closely Associated Persons - GlobeNewsWire
- 17 days ago - Genmab drops as Bernstein cuts on Darzalex patent cliff - Seeking Alpha
- 18 days ago - TIVDAK® (tisotumab vedotin) Approved by European Commission for Previously Treated Recurrent or Metastatic Cervical Cancer - Business Wire